FLGB - ETF AI Analysis
Top Page
Franklin FTSE United Kingdom ETF (FLGB)
FLGB, the Franklin FTSE United Kingdom ETF, earns a solid overall rating thanks to major holdings like HSBC, AstraZeneca, and Rio Tinto, which show strong financial performance, positive earnings calls, and supportive technical trends that lift the fund’s quality. The rating is held back somewhat by names such as Rolls-Royce and Unilever, where financial stability concerns, bearish or weak technical signals, and high valuations introduce more uncertainty. A key risk for FLGB is its concentration in a relatively small set of large UK companies and sectors, meaning setbacks in big holdings like banks, energy, or industrials could have an outsized impact on the ETF.
FLGB vs. SPDR S&P 500 ETF (SPY)
- AUM
- 875.27M
- Region
- Europe
- Expense Ratio
- 0.09%
- Beta
- 0.52
- Issuer
- Franklin
- Inception Date
- Nov 02, 2017
- Dividend Yield
- 2.87%
- Asset Class
- Equity
- Index Tracked
- FTSE UK RIC Capped Index
FLGB Summary
FLGB is the Franklin FTSE United Kingdom ETF, which tracks the FTSE UK RIC Capped Index. It gives you broad exposure to the UK stock market in a single investment, holding companies of many sizes across sectors like finance, energy, health care, and consumer goods. Well-known holdings include Shell and HSBC. Someone might invest in FLGB to diversify outside the U.S. and to capture the overall growth and income potential of the UK market. A key risk is that it is heavily tied to the UK economy, so its value can go up or down with UK market conditions.
How much will it cost me?
This ETF has an expense ratio of 0.09%, which means you’ll pay about $0.90 per year for every $1,000 invested. That’s lower than the average ETF because it’s a passively managed fund that simply tracks a UK stock market index instead of paying managers to pick individual stocks.
What would affect this ETF?
FLGB could benefit if the U.K. economy strengthens, interest rates stabilize or fall, and global demand supports its major sectors like financials, energy, and consumer defensive companies such as HSBC, Shell, and Unilever. On the downside, higher interest rates, slower U.K. growth, weaker commodity prices, or tighter regulations on banks, energy, and tobacco could hurt the fund’s broad U.K. market exposure and its top holdings.
FLGB Top 10 Holdings
FLGB leans heavily on big UK energy and financial names, with Shell and BP doing much of the heavy lifting as their shares have been rising and giving the fund a solid backbone. HSBC, on the other hand, has been lagging lately, acting more like a brake than an engine. In health care, AstraZeneca and GSK are more mixed, with steady fundamentals but softer recent momentum, while consumer giant Unilever is still searching for a stronger spark. Overall, this is a UK-centric play dominated by blue-chip energy, banks, and defensives rather than tech high-flyers.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 GB:SHEL | Shell (UK) | 9.55% | $83.75M | GBP 229.30B | 40.01% | 73Outperform |
 GB:HSBA | HSBC Holdings | 8.88% | $77.86M | GBP 218.81B | 19.37% | 80Outperform |
 AZN | AstraZeneca | ― | ― | ― | ― | 80Outperform |
 GB:RR | Rolls-Royce Holdings | 4.21% | $36.95M | GBP 102.49B | 6.11% | 71Outperform |
 GB:ULVR | Unilever | 4.10% | $35.98M | GBP 104.93B | -6.01% | 72Outperform |
 GB:BP | BP p.l.c. | 3.99% | $34.97M | GBP 96.96B | 40.09% | 71Outperform |
 GB:BATS | British American Tobacco | 3.78% | $33.13M | GBP 98.70B | 17.93% | 71Outperform |
 GB:GSK | GlaxoSmithKline | 3.00% | $26.29M | GBP 74.37B | 4.04% | 77Outperform |
 GB:RIO | Rio Tinto | 2.55% | $22.39M | GBP 105.22B | 11.14% | 82Outperform |
 GB:NG | National Grid | 2.55% | $22.37M | GBP 63.06B | 8.76% | 76Outperform |
FLGB Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For FLGB, the sentiment is Positive. The current price of 36.84 is above the 20-day moving average (MA) of 36.33, above the 50-day MA of 36.62, and above the 200-day MA of 35.76, indicating a bullish trend. The MACD of 0.11 indicates Negative momentum. The RSI at 56.56 is Neutral, neither overbought nor oversold. The STOCH value of 57.55 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FLGB.
FLGB Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| FLGB | $36.84 | $40.00(8.58% Upside) | $875.27M | 0.09% | 72Outperform |
 EWU | $47.83 | $58.86(23.05% Upside) | $3.72B | 0.50% | 73Outperform |
 DBEU | $53.98 | $63.92(18.42% Upside) | $787.99M | 0.46% | 64Neutral |
 SPEU | $53.98 | $63.86(18.30% Upside) | $706.97M | 0.07% | 62Neutral |
 EWUS | $44.26 | $52.64(18.92% Upside) | $40.33M | 0.59% | 66Neutral |
 FKU | $54.55 | $62.37(14.33% Upside) | $35.62M | 0.80% | 68Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| FLGB | Franklin FTSE United Kingdom ETF | 36.84 | 5.17 | 16.33% | |
| EWU | iShares MSCI United Kingdom ETF | 47.83 | 6.70 | 16.28% | |
| DBEU | Xtrackers MSCI Europe Hedged Equity ETF | 53.98 | 7.51 | 16.15% | |
| SPEU | SPDR Portfolio Europe ETF | 53.98 | 5.80 | 12.03% | |
| EWUS | iShares MSCI United Kingdom Small Cap ETF | 44.26 | 5.06 | 12.92% | |
| FKU | First Trust United Kingdom AlphaDEX Fund | 54.55 | 8.57 | 18.65% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.